Addressing Residual Risk Beyond LDL: Aggressively Treating HDL to Reduce CVD

Saturday Symposia

Intended Audience: The intended audience for this activity consists of endocrinologists, cardiologists, family practice physicians, internists, and primary care physicians who treat patients with cardiovascular disease.

Call 1-800-973-0362, or click here, to register now for this exciting event!

Earn up to 5.5 CME credits for this Saturday symposium.

Complimentary Carotid IMT Scanning available
A limited number of attendees will receive a complimentary carotid IMT scan courtesy of CardioRisk Laboratories. This is a safe and non-invasive technique that provides incremental information to traditional risk factor assessment and is a powerful predictor of cardiac death, myocardial infarction, and stroke. Scans will take place prior to and during each symposium on a first-come, first-served basis.

Program Overview: Heart attacks remain the biggest killer in this country and occur approximately every 30 seconds. Strokes are the third leading cause of death, occurring every 45 seconds. Statin outcome trials, even with high dose statin trials, continue to demonstrate a significant residual risk. The Bale/Doneen Method aggressively manages residual lipids beyond LDL and demonstrates dramatic reduction in cardiovascular risk and regression of atherosclerosis. This CME symposium will educate the participant on practical ways to identify those at risk for heart attacks and strokes. It will provide training in administering combination lipid therapy. Additionally, a limited number of participants will receive a carotid intima-media thickness scan. This is a safe and non-invasive technique that augments traditional risk factor assessment and is a powerful predictor of cardiac death, myocardial infarction and stroke.

Learning Objectives: Upon completion of this program, participants should be able to:

1. Accurately identify those at risk for a cardiovascular event
2. Describe and discuss the number one risk factor for acute coronary syndrome, as highlighted by the INTERHEART trial
3. Recognize metabolic syndrome and its associated dyslipidemic lipid profile
4. Gain clinical techniques to recognize insulin resistance and its residual risk beyond LDL
5. Demonstrate techniques for the allocation of combination lipid therapy for global risk management

Program Agenda:

Check back for additional events to take place through November.

Faculty: Bradley F. Bale, MD and Amy L. Doneen, MSN, ARNP

Bradley F. Bale, MD
Medical Director
Advanced Center for the Prevention of Heart Attack, Stroke and Diabetes
Covenant Heart and Vascular Institute
Lubbock, Texas
Clinical Assistant Professor Texas Tech University Health Sciences Center School of Medicine

Amy L. Doneen, MSN, ARNP
Medical Director
Heart Attack & Stroke Prevention Center
Spokane, Washington

Pre-registration for this program is highly encouraged. On-site registration/admittance to the program is not guaranteed and will be based upon seating availability. All on-site registrants may be required to provide professional identification.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Optima Educational Solutions, Inc. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky Colleges of Pharmacy and Medicine require that speakers disclose significant relationships with commercial companies whose product or services are discussed in educational presentations. Full disclosure of significant relationships will be made in writing via handout materials or syllabus.

Designation Statement

The University of California, Irvine School of Medicine designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This program is supported by an educational grant from Abbott Laboratories.

© 2008 Optima Educational Solutions, Inc. All rights reserved.

Admittance to program(s) is subject to the sole discretion of Optima Educational Solutions, Inc. and its authorized representatives.

We comply with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For any special requests, please contact us at least two weeks prior to the start of the event.

University of Kentucky is an Equal Opportunity University.